AusperBio reports AHB-137 sustained functional cure in 16 of 17 evaluable NA-treated hepatitis B patients at 12 months off ...
Brii Bio's Phase IIb ENRICH data show BRII-179 priming drove 42% HBsAg loss in hepatitis B. Read the full results and what they mean for a functional cure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results